We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Up to Two-Thirds of Clinical Trials May Be Done Abroad, Study Says
Up to Two-Thirds of Clinical Trials May Be Done Abroad, Study Says
January 24, 2007
Drug companies will increasingly outsource their clinical trials in the coming years, with "many top pharmaceutical companies" expecting to do up to 65 percent of their clinical trials abroad, according to the "Outlook 2007" survey by the Tufts Center for the Study of Drug Development (CSDD).